The Malaysian Reserve

Calliditas Therapeutics Reports Safety Data for Setanaxib in Patients with Alport Syndrome at the American Society of Nephrology Kidney Week

Calliditas Therapeutics (Calliditas), an Asahi Kasei company, announced today that primary safety endpoints of a ...